02196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 16.20
+0.37%Leverage
- Debt / equity
- 0.81x
- Net debt / equity
- 0.53x
- Debt / assets
- 0.31x
- Debt / EBITDA
- 5.33x
- Net debt / EBITDA
- 3.49x
Liquidity & coverage
- Current ratio
- 0.90x
- Quick ratio
- 0.75x
- Cash ratio
- 0.42x
- Interest coverage
- 3.47x
- EBITDA / interest
- 5.02x
- Working capital
- -HKD 4.4B
Cash & dividend
- FCF / debt
- 0.02x
- Cash flow / debt
- 0.14x
- Dividend per share
- HKD 0.45
- Dividend yield
- 2.8%
- Dividend growth 1y
- +28.6%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026